Mac387: its non-specificity as a tumour marker or marker of histiocytes
- PMID: 1916699
- DOI: 10.1111/j.1365-2559.1991.tb00030.x
Mac387: its non-specificity as a tumour marker or marker of histiocytes
Abstract
A commercially available monoclonal antibody which detects histiocytes in paraffin sections, Mac387, was reacted with 148 soft tissue sarcomas, 29 carcinomas and 10 malignant melanomas. The soft tissue sarcomas had been previously immunophenotyped. All categories of sarcomas, with the exception of angiosarcomas, were positive. Most showed staining in less than 50% of the tumour cells. Six of 10 adenocarcinomas and three of nine basal cell carcinomas were positive, while squamous carcinomas and malignant melanomas were negative. Normal squamous mucosa and epidermis were also positive. The results of this study suggest that Mac387 is of little value in the differential diagnosis of soft tissue tumours, nor is it a specific histiocytic marker.
Comment in
-
MAC387: its non-specificity as a tumour marker or marker of histiocytes.Histopathology. 1992 Aug;21(2):199-200. doi: 10.1111/j.1365-2559.1992.tb00376.x. Histopathology. 1992. PMID: 1324222 No abstract available.
Similar articles
-
KP-1: not a specific marker. Staining of 137 sarcomas, 48 lymphomas, 28 carcinomas, 7 malignant melanomas and 8 cystosarcoma phyllodes.Virchows Arch. 1994;424(6):635-40. doi: 10.1007/BF00195778. Virchows Arch. 1994. PMID: 7519954 Review.
-
Anti-alpha 1-antichymotrypsin staining of 194 sarcomas, 38 carcinomas, and 17 malignant melanomas. Its lack of specificity as a tumour marker.Am J Surg Pathol. 1987 Feb;11(2):133-9. doi: 10.1097/00000478-198702000-00007. Am J Surg Pathol. 1987. PMID: 2433954 Review.
-
Vimentin: an evaluation of its role as a tumour marker.Histopathology. 1987 Jan;11(1):63-72. doi: 10.1111/j.1365-2559.1987.tb02609.x. Histopathology. 1987. PMID: 2435649
-
Antineuron specific enolase staining reactions in sarcomas and carcinomas: its lack of neuroendocrine specificity.J Clin Pathol. 1986 Nov;39(11):1186-92. doi: 10.1136/jcp.39.11.1186. J Clin Pathol. 1986. PMID: 3540015 Free PMC article.
-
"Histiocytic markers" in melanoma.Mod Pathol. 1999 Nov;12(11):1072-7. Mod Pathol. 1999. PMID: 10574605 Clinical Trial.
Cited by
-
Functional and clinical aspects of the myelomonocyte protein calprotectin.Mol Pathol. 1997 Jun;50(3):113-23. doi: 10.1136/mp.50.3.113. Mol Pathol. 1997. PMID: 9292145 Free PMC article. Review. No abstract available.
-
Immunological tumor status may predict response to neoadjuvant chemotherapy and outcome after radical cystectomy in bladder cancer.Sci Rep. 2017 Oct 4;7(1):12682. doi: 10.1038/s41598-017-12892-5. Sci Rep. 2017. PMID: 28978923 Free PMC article.
-
CD68 positive and/or CD163 positive tumor-associated macrophages and PD-L1 expression in breast phyllodes tumor.Breast Cancer Res Treat. 2025 Jan;209(2):261-273. doi: 10.1007/s10549-024-07487-4. Epub 2024 Sep 6. Breast Cancer Res Treat. 2025. PMID: 39242456
-
KP-1: not a specific marker. Staining of 137 sarcomas, 48 lymphomas, 28 carcinomas, 7 malignant melanomas and 8 cystosarcoma phyllodes.Virchows Arch. 1994;424(6):635-40. doi: 10.1007/BF00195778. Virchows Arch. 1994. PMID: 7519954 Review.
-
Chondroblastoma of bone. A clinical, radiological, light and immunohistochemical study.Virchows Arch A Pathol Anat Histopathol. 1992;421(4):355-66. doi: 10.1007/BF01660984. Virchows Arch A Pathol Anat Histopathol. 1992. PMID: 1384228
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical